HOME >> MEDICINE >> NEWS
ACPM recommends research priorities for child and adolescent immunizations

Washington, D.C. - The American College of Preventive Medicine (ACPM) recommended today research priorities that aim to encourage the development of new vaccines and increase immunization rates. Developing new combinations of vaccines and needleless vaccine delivery systems are among the key recommendations. If implemented on a population-wide basis, such improvements would increase immunization rates by reducing the inefficiency of multiple injections and by minimizing the emotional and physical trauma in children.

According to Dr. Yemisi Adetunji, the lead author of ACPM's recommendations, "Despite the incontrovertible evidence that vaccines are an efficient and cost-effective means of reducing morbidity and mortality, immunization delivery remains suboptimal among young children.

Immunization rates in areas of poverty and many metropolitan areas with large populations of low-income residents remain below national levels. We can do better to protect our children's health."

Other research priorities from ACPM address issues of vaccine supply, the effectiveness of recommended interventions, and better funding for immunization programs. In addition to its research priorities, ACPM recommends that all children and adolescents without established contraindications receive immunization against 11 diseases: diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, H. influenza b (Hib), hepatitis B, varicella (i.e., chickenpox), and S. pneumoniae. The ACPM recommendations are in accordance with the schedule of childhood immunizations recommended by the Advisory Committee on Immunization Practices.

ACPM's recommendations on childhood immunizations appear in the August 2003 issue of the American Journal of Preventive Medicine. The statement can be viewed at http://www.acpm.org .


'"/>

Contact: Jennifer K. Bretsch
jkb@acpm.org
202-466-2044
American College of Preventive Medicine
13-Aug-2003


Page: 1

Related medicine news :

1. Mayo Clinic recommends broadening treatment to battle recurrence of endometrial cancer
2. IDSA recommends ways to strengthen HHSs pandemic influenza plan
3. ACPM recommends reproductive health care benefits for adolescents
4. Study recommends 50% reduction in CT radiation dose based on patient size and weight
5. Foot and mouth report recommends major changes to the lamb supply chain
6. FDA advisory committee recommends approval of novantrone for treatment of worsening multiple sclerosis
7. Public morally obliged to take part in scientific research, says leading ethicist
8. U of M researcher says Viagra may cause permanent vision loss in some men
9. Indiana University researchers closer to helping hearing-impaired using stem cells
10. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
11. RIT takes eye-tracking research to next level

Post Your Comments:
(Date:5/20/2013)... Illinois (PRWEB) May 20, 2013 ... living community in Lake County, Illinois, is hosting Breakfast ... , The community, which is located at 3775 Grand ... incomes, including those on Medicaid, who need some help ... delicious breakfast buffet and games of bingo," says Tammy ...
(Date:5/20/2013)... 2013 When people have ... to become a celebrity. New Jersey governor Chris ... News report (“Chris Christie Says Lap Band Surgery ... the surgery was not done so that he ... status as a former lap band patient. Simply ...
(Date:5/20/2013)... In order to prepare for the long hot days ... launched an article series to raise awareness about skincare health ... with the precautions that need to be taken in ... not one of the 3.5 million cases of skin cancer ... all skin cancer cases are associated with exposure to sunlight ...
(Date:5/20/2013)... 21, 2013 People are so busy these ... levels are through the roof and are contributing to a ... stress could mean the difference between life and death. Speakers ... on 29 May will share valuable, practical tools people can ... the world around them for social good. , Organised by ...
(Date:5/20/2013)... May 20, 2013 The ... will feature dozens of continuing education credit opportunities ... American Institute of Architects Continuing Education System (AIA/CES), ... and the Interior Design Continuing Education Council (IDCEC). ... June 1, 2013 at the Omni Providence Hotel ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Combat Skin Cancer In Summer Months 2Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2
(Date:5/20/2013)... SAN DIEGO , May 20, 2013 ... in Elcelyx Therapeutics, Phase 2b dose-finding clinical trial of ... generic metformin, the foundational treatment for Type 2 diabetes. ... the multicenter U.S. program in June. Results of the ... are expected in late summer, and the read-out for ...
(Date:5/20/2013)... 20, 2013  Neuralstem, Inc. (NYSE MKT: CUR) today ... PhD, principal investigator, presented updated Phase I data from ... in the treatment of amyotrophic lateral sclerosis (ALS or ... neuro diabetes special medical symposium in Bucharest, ... "Recent Therapeutic Advances in Stem Cell Therapy," Dr. Feldman ...
(Date:5/20/2013)... May 20, 2013 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that surveyed ... a greater effect on quality of life is ... the high level of subjectivity and variability of ... thought leaders state that it is difficult to ...
Breaking Medicine Technology:Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2
Cached News: